Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Forward the spam you receive to questions@spamdex.co.uk

Also in politico.com

POLITICO New York Health Care: DSH cuts coming -- Workers' comp fight -- Graham-Cassidy hitting the skids

By Dan Goldberg | 09/12/2017 09:59 AM EDT

DSH CUTS COMING — The Disproportionate Share Hospital cuts the industry has feared for years are scheduled to begin taking effect in less than three weeks, creating a tough choice for the Cuomo administration, which may have to decide how to apportion a much smaller pot of money. New York stands to lose $329 million in federal payments, according to a proposed rule from the Centers for Medicare and Medicaid Services. That's 16 percent of New York's total allotment and the largest cut, in terms of dollars, for any state. Read more here.

NOW WE KNOW Your dog may really love you, and not just for the food and tummy rubs, according to a new book called "What It's Like to Be a Dog." The author is Dr. Gregory Berns, 53, a neuroscientist at Emory University in Atlanta, who spends his days scanning the brains of dogs, trying to figure out what they're thinking, according to The New York Times.

WORKERS' COMP — Leading state labor figures, including the AFL-CIO, are opposed to new impairment guidelines proposed by the Workers' Compensation Board. They argue that they will drastically reduce payments for workers who've suffered impairment that diminishes their capacity to work, while business advocates argue that the previous standards were out-of-date relative to medical advancement. Read more here.

BREAST CANCER GUIDELINES — Montefiore surgeons, writing in the Annals of Surgical Oncology, have new guidelines for treating breast cancer related lymphedema, a side effect of surgery and radiation. "The swelling, which can impair arm mobility, frequently happens just when people are starting to regain their energy and resume their lives following breast cancer treatment," Dr. Sheldon Feldman, chief of the Division of Breast Surgery and Surgical Oncology and Director of Breast Cancer Services at Montefiore Einstein Center for Cancer Care, the clinical arm of the NCI-designated Albert Einstein Cancer Center, said in a press release. The guidelines include establishing surveillance plans with baseline measurements at diagnosis to prevent BCRL progression by ensuring proper follow up. It is also recommended that more patients undergo "axillary reverse mapping," which preserves healthy lymph nodes in the armpit, as only breast cancer specific lymph nodes are impacted by surgery.

MAKE SURE YOU FOLLOW Dan on Twitter @DanCGoldberg and Nick @NickNiedz. And for all New Jersey health news, check out @katiedjennings.

WE'D LOVE TO HEAR FROM YOU: This roundup is for you, so please tell us how we can make it even better. Send tips, news, ideas, calendar items, releases, promotions, job postings, birthdays, congratulations, criticisms and corrections to dgoldberg@politico.com.

PHARMA REPORT:

PHARMA LOSES IN CA — California's Assembly Monday evening passed a drug transparency bill that has been hotly contested by the pharmaceutical industry. CA Senate Bill 17 would require drugmakers to give advance notification of substantial price hikes and health plans would have to disclose which drugs cost them the most. The measure passed 59-10 and now heads to the Senate, which already passed an earlier version and is expected to approve the latest changes. The bill would then go to Gov. Jerry Brown's desk.

ASTHMA DRUG FAILS — Reuters reports

WHAT WE'RE READING:

MUST READ JOURNALISM — The Cincinnati Enquirer sent more than 60 reporters, photographers and videographers into their communities to chronicle the heroin epidemic for one week. Read it here.

THIS ISN'T GOOD — Guess which company holds the contract to check incomes and other data of people who purchase insurance in the Obamacare markets. Yep, it is Equifax Inc., which said last week it suffered a breach that exposed the personal data of 143 million Americans. Bloomberg has the story.

GRAHAM-CASSIDY HITTING SKIDS? — The last-ditch Obamacare repeal-and-replace plan didn't make its promised debut on Monday, the latest hiccup for the bill still being crafted by Sens. Lindsey Graham, Bill Cassidy and Dean Heller. Cassidy said he's already been running pieces of the bill past staffers at the Congressional Budget Office and is hoping to now unveil the legislation on Wednesday.

... But Orrin Hatch is pessimistic. The Senate Finance Committee chairman told reporters on Monday that he doesn't think the yet-to-be-released plan will get a floor vote, echoing Senate Majority Whip John Cornyn's comments last week and the pessimism from other leading Republicans. And Rand Paul said the bill is a "bad idea."

HOUSE DEMS TO INTRO MEDICARE BUY-IN PLAN TODAY — The plan would allow Americans aged 50 through 64 to buy into Medicare Parts A, B and D for a premium potentially as low as $8,212 per year, significantly cheaper than many Silver and Gold insurance plans available for older Americans on the ACA exchanges. "Aspirationally, people want single payer," co-author Rep. John Larson told POLITICO. "And hey, I agree with [them]. Realistically, I think we have a more ... doable approach to get there" through Medicare buy-in.

... What else is in it: The proposal includes other changes to the Medicare program, such as allowing Medicare to negotiate drug prices — a provision that Larson notes has bipartisan appeal and is projected to lower the program's drug spending by 24 percent. It would also create a new commission with power to address Medicare's long-term costs and increase program funding to fight fraud and abuse. The legislation also would include measures intended to shore up Obamacare, such as guaranteeing funding for the law's cost-sharing reductions, extending the ACA's risk corridors through 2020 and re-establishing its reinsurance program.

PULSE CHECK: WHEN POLITICIANS USED MEDICARE AS A PIGGY BANK — A late-night deal more than a decade ago let politicians make Medicare changes to benefit hospitals and ultimately reap higher campaign contributions, argues a Yale economist — who says he's got the evidence to prove it. There's "a really close link between how Medicare sets its payment policies and some of the games that politicians play and the electoral process," economist Zack Cooper said on POLITICO's "Pulse Check" podcast . "Part of the reason we struggle so much with constraining health care spending actually has to do with the politics." Listen to the podcast.

HARVEY — "Floodwaters in two Houston neighborhoods have been contaminated with bacteria and toxins that can make people sick, testing organized by The New York Times has found. Residents will need to take precautions to return safely to their homes, public health experts said. It is not clear how far the toxic waters have spread."

SOLEMN TASK — The New York Times editorial board writes about the ongoing work of matching 9/11 victims to their remains: "For the chief medical examiner, Dr. Barbara Sampson, and her staff, the terrorist attacks of Sept. 11, 2001, are never past. All these years later, the team still strives to scientifically identify each of the 2,753 people who were killed in the destruction of the twin towers."

TODAY'S TIP — Comes from the Cleveland Clinic, which shares tips to help patients find a doctor who is a partner in care.

STUDY THIS:

ANOTHER IMMUNOTHERAPY REVELATION — Nivolumab was shown to be more effective for treating patients with resected stage III and stage IV melanoma than ipilimumab, the current standard of care, according to a study from researchers at NYU Langone Health's Perlmutter Cancer Center published in the New England Journal of Medicine. Here is a video of Dr. Jeffrey Weber explaining his findings.

CAN'T QUIT YOU — Cocaine addicts enjoy cocaine less as the years go on but still have trouble quitting, and researchers from the Icahn School of Medicine at Mount Sinai think they know why, according to a study in Addiction Biology. Read more here.

DRUG DEVELOPMENT COSTS MUCH LESS THAN INDUSTRY ESTIMATES — It typically costs pharmaceutical companies $648 million for research and development to bring a cancer drug to market, much less than what the industry often claims, according to a new study in JAMA Internal Medicine.

MISSED A ROUNDUP? Get caught up here.

To view online:
http://www.politico.com/states/new-york/tipsheets/politico-new-york-health-care/2017/09/12/dsh-cuts-coming-008523

You received this POLITICO content because your customized settings include: POLITICO New York Health Care. To change your alert settings, please go to https://www.politicopro.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to unsubscribe.



---------------------------

All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Lets beat spam together
Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address!
Please use spamdex responsibly.


Yes You! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to questions@spamdex.co.uk | See contributors

Google + Spam | 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at questions@spamdex.co.uk. Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations. Special thanks: We would like to thank Benedict who is a SEO Consultant who has freely given up his time to advise us on how best to maximise on our organic search traffic strategy and also for his wonderful creative vision on how to spread the word about Spamdex and how we try to combat spam across the globe. Click here for more information.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See https://archive.org. Spamdex is in no way associated though. Supporters and members of http://spam.abuse.net Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.8 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 080000 0514541.